vs
Side-by-side financial comparison of Life Time Group Holdings, Inc. (LTH) and QuidelOrtho Corp (QDEL). Click either name above to swap in a different company.
Life Time Group Holdings, Inc. is the larger business by last-quarter revenue ($745.1M vs $699.9M, roughly 1.1× QuidelOrtho Corp). Life Time Group Holdings, Inc. runs the higher net margin — 16.5% vs -104.7%, a 121.2% gap on every dollar of revenue. On growth, Life Time Group Holdings, Inc. posted the faster year-over-year revenue change (12.3% vs -3.7%). Life Time Group Holdings, Inc. produced more free cash flow last quarter ($-64.6M vs $-94.7M). Over the past eight quarters, Life Time Group Holdings, Inc.'s revenue compounded faster (11.7% CAGR vs -2.9%).
Life Time Group Holdings, Inc. operates a network of premium athletic, fitness and wellness destinations across the United States. It offers diverse services including state-of-the-art gym facilities, group exercise classes, personal training, spa treatments, nutrition coaching, youth programs and co-working spaces for consumers pursuing holistic healthy lifestyles.
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
LTH vs QDEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $745.1M | $699.9M |
| Net Profit | $123.0M | $-733.0M |
| Gross Margin | 49.1% | — |
| Operating Margin | 17.4% | -100.7% |
| Net Margin | 16.5% | -104.7% |
| Revenue YoY | 12.3% | -3.7% |
| Net Profit YoY | 231.0% | -3583.4% |
| EPS (diluted) | $0.55 | $-10.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $745.1M | — | ||
| Q3 25 | $782.6M | $699.9M | ||
| Q2 25 | $761.5M | $613.9M | ||
| Q1 25 | $706.0M | $692.8M | ||
| Q4 24 | $663.3M | $707.8M | ||
| Q3 24 | $693.2M | $727.1M | ||
| Q2 24 | $667.8M | $637.0M | ||
| Q1 24 | $596.7M | $711.0M |
| Q4 25 | $123.0M | — | ||
| Q3 25 | $102.4M | $-733.0M | ||
| Q2 25 | $72.1M | $-255.4M | ||
| Q1 25 | $76.1M | $-12.7M | ||
| Q4 24 | $37.2M | $-178.4M | ||
| Q3 24 | $41.4M | $-19.9M | ||
| Q2 24 | $52.8M | $-147.7M | ||
| Q1 24 | $24.9M | $-1.7B |
| Q4 25 | 49.1% | — | ||
| Q3 25 | 47.1% | — | ||
| Q2 25 | 47.0% | — | ||
| Q1 25 | 47.5% | — | ||
| Q4 24 | 48.2% | — | ||
| Q3 24 | 46.5% | — | ||
| Q2 24 | 46.8% | — | ||
| Q1 24 | 46.1% | — |
| Q4 25 | 17.4% | — | ||
| Q3 25 | 17.3% | -100.7% | ||
| Q2 25 | 14.2% | -29.4% | ||
| Q1 25 | 15.2% | 4.7% | ||
| Q4 24 | 13.1% | -14.2% | ||
| Q3 24 | 13.5% | 2.1% | ||
| Q2 24 | 15.7% | -18.4% | ||
| Q1 24 | 12.1% | -247.3% |
| Q4 25 | 16.5% | — | ||
| Q3 25 | 13.1% | -104.7% | ||
| Q2 25 | 9.5% | -41.6% | ||
| Q1 25 | 10.8% | -1.8% | ||
| Q4 24 | 5.6% | -25.2% | ||
| Q3 24 | 6.0% | -2.7% | ||
| Q2 24 | 7.9% | -23.2% | ||
| Q1 24 | 4.2% | -239.9% |
| Q4 25 | $0.55 | — | ||
| Q3 25 | $0.45 | $-10.78 | ||
| Q2 25 | $0.32 | $-3.77 | ||
| Q1 25 | $0.34 | $-0.19 | ||
| Q4 24 | $0.17 | $-2.54 | ||
| Q3 24 | $0.19 | $-0.30 | ||
| Q2 24 | $0.26 | $-2.20 | ||
| Q1 24 | $0.12 | $-25.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $204.8M | $98.1M |
| Total DebtLower is stronger | $1.5B | $2.5B |
| Stockholders' EquityBook value | $3.1B | $2.0B |
| Total Assets | $8.0B | $5.7B |
| Debt / EquityLower = less leverage | 0.48× | 1.23× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $204.8M | — | ||
| Q3 25 | $218.9M | $98.1M | ||
| Q2 25 | $175.5M | $151.7M | ||
| Q1 25 | $59.0M | $127.1M | ||
| Q4 24 | $10.9M | $98.3M | ||
| Q3 24 | $120.9M | $143.7M | ||
| Q2 24 | $34.5M | $107.0M | ||
| Q1 24 | $18.6M | $78.5M |
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | $2.5B | ||
| Q2 25 | $1.5B | $2.1B | ||
| Q1 25 | $1.5B | $2.1B | ||
| Q4 24 | $1.5B | $2.1B | ||
| Q3 24 | $1.7B | $2.2B | ||
| Q2 24 | $1.8B | $2.2B | ||
| Q1 24 | $2.0B | $2.2B |
| Q4 25 | $3.1B | — | ||
| Q3 25 | $3.0B | $2.0B | ||
| Q2 25 | $2.9B | $2.8B | ||
| Q1 25 | $2.7B | $3.0B | ||
| Q4 24 | $2.6B | $3.0B | ||
| Q3 24 | $2.6B | $3.2B | ||
| Q2 24 | $2.4B | $3.2B | ||
| Q1 24 | $2.3B | $3.3B |
| Q4 25 | $8.0B | — | ||
| Q3 25 | $7.8B | $5.7B | ||
| Q2 25 | $7.6B | $6.4B | ||
| Q1 25 | $7.3B | $6.5B | ||
| Q4 24 | $7.2B | $6.4B | ||
| Q3 24 | $7.2B | $6.8B | ||
| Q2 24 | $7.1B | $6.7B | ||
| Q1 24 | $7.1B | $6.7B |
| Q4 25 | 0.48× | — | ||
| Q3 25 | 0.51× | 1.23× | ||
| Q2 25 | 0.53× | 0.74× | ||
| Q1 25 | 0.56× | 0.70× | ||
| Q4 24 | 0.59× | 0.72× | ||
| Q3 24 | 0.64× | 0.68× | ||
| Q2 24 | 0.78× | 0.70× | ||
| Q1 24 | 0.87× | 0.68× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $239.9M | $-45.5M |
| Free Cash FlowOCF − Capex | $-64.6M | $-94.7M |
| FCF MarginFCF / Revenue | -8.7% | -13.5% |
| Capex IntensityCapex / Revenue | 40.9% | 7.0% |
| Cash ConversionOCF / Net Profit | 1.95× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-21.0M | $-153.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $239.9M | — | ||
| Q3 25 | $251.1M | $-45.5M | ||
| Q2 25 | $195.7M | $-46.8M | ||
| Q1 25 | $183.9M | $65.6M | ||
| Q4 24 | $163.1M | $63.7M | ||
| Q3 24 | $151.1M | $117.9M | ||
| Q2 24 | $170.4M | $-97.9M | ||
| Q1 24 | $90.4M | $-700.0K |
| Q4 25 | $-64.6M | — | ||
| Q3 25 | $28.6M | $-94.7M | ||
| Q2 25 | $-26.3M | $-84.3M | ||
| Q1 25 | $41.4M | $9.4M | ||
| Q4 24 | $26.8M | $16.5M | ||
| Q3 24 | $64.0M | $71.4M | ||
| Q2 24 | $26.1M | $-133.2M | ||
| Q1 24 | $-66.4M | $-66.8M |
| Q4 25 | -8.7% | — | ||
| Q3 25 | 3.7% | -13.5% | ||
| Q2 25 | -3.5% | -13.7% | ||
| Q1 25 | 5.9% | 1.4% | ||
| Q4 24 | 4.0% | 2.3% | ||
| Q3 24 | 9.2% | 9.8% | ||
| Q2 24 | 3.9% | -20.9% | ||
| Q1 24 | -11.1% | -9.4% |
| Q4 25 | 40.9% | — | ||
| Q3 25 | 28.4% | 7.0% | ||
| Q2 25 | 29.2% | 6.1% | ||
| Q1 25 | 20.2% | 8.1% | ||
| Q4 24 | 20.6% | 6.7% | ||
| Q3 24 | 12.6% | 6.4% | ||
| Q2 24 | 21.6% | 5.5% | ||
| Q1 24 | 26.3% | 9.3% |
| Q4 25 | 1.95× | — | ||
| Q3 25 | 2.45× | — | ||
| Q2 25 | 2.71× | — | ||
| Q1 25 | 2.41× | — | ||
| Q4 24 | 4.39× | — | ||
| Q3 24 | 3.65× | — | ||
| Q2 24 | 3.23× | — | ||
| Q1 24 | 3.63× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LTH
| Membership | $535.1M | 72% |
| In Center | $191.2M | 26% |
| Other | $18.8M | 3% |
QDEL
| Labs | $373.8M | 53% |
| Point Of Care | $164.6M | 24% |
| Immunohematology | $142.0M | 20% |
| Donor Screening | $14.7M | 2% |
| Molecular Diagnostics | $4.8M | 1% |
| Collaborative Arrangement Transaction With Party To Collaborative Arrangement | $2.1M | 0% |
